Short answer
IDEAYA Biosciences, Inc. (IDYA) filed an 8-K current report with the SEC on June 23, 2026 reporting Item 5.07 (Submission of Matters to a Vote of Security Holders), Item 8.01 (Other Events). All three Class I director nominees elected; terms run through 2029.
IDEAYA Biosciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All three Class I director nominees elected; terms run through 2029
- Director support varied, with Hampton receiving 56.7M votes for versus 16.3M withheld
- PwC auditor selection ratified by 82.6M votes for, with 141,240 against
- Executive compensation approved on an advisory basis by 64.3M votes for versus 8.3M against
- 10.1M broker non-votes affected director and compensation proposals, but not auditor ratification
Item 8.01 · Other Events
- Yujiro S. Hata elected Board Chairman effective June 16, 2026
- Terry Rosen, Ph.D. appointed Lead Independent Director
- Leadership structure separates chair and independent oversight roles, relevant to governance and investor confidence
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other IDEAYA Biosciences, Inc. 8-K filings
Get the next IDYA 8-K as it lands
Follow IDYA for push alerts, or ask the research agent what this filing means.